Article
Predicting antifolate resistance in the unculturable fungal pathogen <i>Pneumocystis jirovecii</i>
2025-05-08
Abstract excerpt
Pneumocystis jirovecii is a fungal pathogen causing Pneumocystis pneumonia in humans, mainly in immunocompromised individuals. Infections by P. jirovecii are treated using the antifolate combination drug trimethoprim-sulfamethoxazole (TMP-SMX), targeting the dihydrofolate reductase (DHFR) and the dihydropteroate synthase (DHPS). In recent years, there has been an increase of treatment failure, with no mutations o...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c739f94d-d857-598f-8a0a-953cf6356720
- DOI
- 10.1101/2025.05.07.652661
